Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
elzovantinib (TPX-0022)
i
Other names:
TPX-0022, TPX 0022, TPX0022
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(8)
News
Trials
Company:
BMS, ZAI Lab
Drug class:
Src kinase inhibitor, c-MET inhibitor, CSF-1R inhibitor
Related drugs:
‹
dasatinib (215)
bosutinib (46)
AZD0530 (7)
BAL3833 (4)
NXP900 (3)
PP2 (2)
TPX-0046 (2)
AZD 0424 (0)
JNJ-26483327 (0)
tirbanibulin ointment (0)
XL228 (0)
KX2-391 oral (0)
savolitinib (29)
amivantamab-vmjw (25)
tepotinib (24)
capmatinib (23)
CKD-702 (6)
LY2801653 (6)
TQ-B3101 (6)
GB263T (5)
gumarontinib (5)
WXSH0011 (5)
ARQ 197 (5)
REGN5093 (4)
MGCD265 (4)
AMG 102 (4)
envonalkib (3)
MCLA-129 (3)
ABN401 (3)
BPI-9016M (2)
HQP8361 (2)
HS-10241 (2)
S95027 (2)
APL-101 (2)
AV-299 (2)
GSK1363089 (2)
DO-1 (1)
GST-HG16 (1)
JNJ-38877605 (1)
KRC-108 (1)
SGX523 (1)
SU11274 (1)
LY2875358 (1)
E7050 (1)
RG3638 (1)
AL2846 (0)
AMG 208 (0)
AMG 337 (0)
ARGX-111 (0)
ASKC202 (0)
ASLAN002 (0)
DO-2 (0)
EMD 1204831 (0)
HLX55 (0)
MRX34 (0)
PF-04217903 (0)
PHA665752 (0)
PM1080 (0)
RXDX-106 (0)
S-49076 (0)
SAIT301 (0)
SAR 125844 (0)
SPH 3348 (0)
TAVO412 (0)
DCC-2701 (0)
Ami-LC (0)
EMB-01 (0)
BMS-794833 (0)
h224G11 (0)
XL092 (0)
avapritinib (13)
pexidartinib (6)
pacritinib (3)
HX301 (2)
vorolanib (1)
OPN-7486 (1)
BMS-986227 (1)
CS 2164 (1)
ABSK021 (1)
AMB-05X (0)
C019199 (0)
HH185 (0)
LY3022855 (0)
NMS-088 (0)
axatilimab-csfr (0)
SU 14813 (0)
SYHA1813 (0)
Q702 (0)
SYHA1817 (0)
BLZ-945 (0)
DCC-3014 (0)
dasatinib (215)
bosutinib (46)
AZD0530 (7)
BAL3833 (4)
NXP900 (3)
PP2 (2)
TPX-0046 (2)
AZD 0424 (0)
JNJ-26483327 (0)
tirbanibulin ointment (0)
XL228 (0)
KX2-391 oral (0)
savolitinib (29)
amivantamab-vmjw (25)
tepotinib (24)
capmatinib (23)
CKD-702 (6)
LY2801653 (6)
TQ-B3101 (6)
GB263T (5)
gumarontinib (5)
WXSH0011 (5)
ARQ 197 (5)
REGN5093 (4)
MGCD265 (4)
AMG 102 (4)
envonalkib (3)
MCLA-129 (3)
ABN401 (3)
BPI-9016M (2)
HQP8361 (2)
HS-10241 (2)
S95027 (2)
APL-101 (2)
AV-299 (2)
GSK1363089 (2)
DO-1 (1)
GST-HG16 (1)
JNJ-38877605 (1)
KRC-108 (1)
SGX523 (1)
SU11274 (1)
LY2875358 (1)
E7050 (1)
RG3638 (1)
AL2846 (0)
AMG 208 (0)
AMG 337 (0)
ARGX-111 (0)
ASKC202 (0)
ASLAN002 (0)
DO-2 (0)
EMD 1204831 (0)
HLX55 (0)
MRX34 (0)
PF-04217903 (0)
PHA665752 (0)
PM1080 (0)
RXDX-106 (0)
S-49076 (0)
SAIT301 (0)
SAR 125844 (0)
SPH 3348 (0)
TAVO412 (0)
DCC-2701 (0)
Ami-LC (0)
EMB-01 (0)
BMS-794833 (0)
h224G11 (0)
XL092 (0)
avapritinib (13)
pexidartinib (6)
pacritinib (3)
HX301 (2)
vorolanib (1)
OPN-7486 (1)
BMS-986227 (1)
CS 2164 (1)
ABSK021 (1)
AMB-05X (0)
C019199 (0)
HH185 (0)
LY3022855 (0)
NMS-088 (0)
axatilimab-csfr (0)
SU 14813 (0)
SYHA1813 (0)
Q702 (0)
SYHA1817 (0)
BLZ-945 (0)
DCC-3014 (0)
›
Associations
(8)
News
Trials
VERI cancer hierarchy
Reset Filters
MET amplification
Gastric Cancer
MET amplification
Gastric Cancer
TPX-0022
Sensitive: C2 – Inclusion Criteria
TPX-0022
Sensitive
:
C2
TPX-0022
Sensitive: C2 – Inclusion Criteria
TPX-0022
Sensitive
:
C2
MET mutation
Gastric Cancer
MET mutation
Gastric Cancer
TPX-0022
Sensitive: C2 – Inclusion Criteria
TPX-0022
Sensitive
:
C2
TPX-0022
Sensitive: C2 – Inclusion Criteria
TPX-0022
Sensitive
:
C2
MET exon 14 deletion
Non Small Cell Lung Cancer
MET exon 14 deletion
Non Small Cell Lung Cancer
TPX-0022
Sensitive: C3 – Early Trials
TPX-0022
Sensitive
:
C3
TPX-0022
Sensitive: C3 – Early Trials
TPX-0022
Sensitive
:
C3
MET amplification
Colorectal Cancer
MET amplification
Colorectal Cancer
TPX-0022
Sensitive: C3 – Early Trials
TPX-0022
Sensitive
:
C3
TPX-0022
Sensitive: C3 – Early Trials
TPX-0022
Sensitive
:
C3
MET H1094Y
Non Small Cell Lung Cancer
MET H1094Y
Non Small Cell Lung Cancer
TPX-0022
Sensitive: C4 – Case Studies
TPX-0022
Sensitive
:
C4
TPX-0022
Sensitive: C4 – Case Studies
TPX-0022
Sensitive
:
C4
MET F1200I
Non Small Cell Lung Cancer
MET F1200I
Non Small Cell Lung Cancer
TPX-0022
Sensitive: C4 – Case Studies
TPX-0022
Sensitive
:
C4
TPX-0022
Sensitive: C4 – Case Studies
TPX-0022
Sensitive
:
C4
MET F1200I
Lung Adenocarcinoma
MET F1200I
Lung Adenocarcinoma
TPX-0022
Sensitive: C4 – Case Studies
TPX-0022
Sensitive
:
C4
TPX-0022
Sensitive: C4 – Case Studies
TPX-0022
Sensitive
:
C4
MET H1094Y
Lung Adenocarcinoma
MET H1094Y
Lung Adenocarcinoma
TPX-0022
Sensitive: C4 – Case Studies
TPX-0022
Sensitive
:
C4
TPX-0022
Sensitive: C4 – Case Studies
TPX-0022
Sensitive
:
C4
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login